Cenni Sabrina, Colucci Antonio, Salomone Simona, Pacella Daniela, Casertano Marianna, Buono Pietro, Martinelli Massimo, Miele Erasmo, Staiano Annamaria, Strisciuglio Caterina
Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Department of Woman, Child and General and Specialist Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy.
J Pediatr Gastroenterol Nutr. 2025 May;80(5):799-806. doi: 10.1002/jpn3.70005. Epub 2025 Feb 11.
Functional constipation (FC) is a common problem in childhood and the first-line therapy is macrogol. The role of FC in the onset of inflammatory bowel disease (IBD) is poorly understood. Our main aim was to investigate the prevalence of FC in children before the diagnosis of IBD.
This is a cross-sectional observational study in pediatric IBD-patients. We collected data on demographics, clinical and endoscopic characteristics at IBD diagnosis, and on the presence of FC and its treatment before IBD diagnosis.
A total of 238 children with IBD, 104 (44%) with Crohn disease (CD), 130 (56%) with ulcerative colitis (UC) and 4 (0.016%) with IBD Unclassified (IBD-U) were enrolled. The mean age was 174 ± 47 months, 56% were male. Forty-seven out of 238 (19.7%) had a FC history before the IBD diagnosis and 31 out of these 47 patients (65%) received macrogol therapy. In the FC group, we found a delay in the diagnosis of IBD compared to the group with no FC [median (interquartile range [IQR]): 5 months (2.5-9.5) and 2 months (0-4), respectively, p ≤ 0.001]. The difference in terms of endoscopic localization was statistically significant in UC patients presenting FC (p = 0.026) with a prevalence of proctitis and left side colitis (30% and 15%, respectively).
In conclusion our study highlighted a prevalence of constipation in pediatric IBD patients at diagnosis of 19.7%, which must be taken into account to avoid diagnostic delay and which is associated with limited extent of disease in UC pediatric patients.
功能性便秘(FC)是儿童期常见问题,一线治疗药物是聚乙二醇。FC在炎症性肠病(IBD)发病中的作用尚不清楚。我们的主要目的是调查IBD诊断前儿童中FC的患病率。
这是一项针对儿科IBD患者的横断面观察性研究。我们收集了IBD诊断时的人口统计学、临床和内镜特征数据,以及IBD诊断前FC的存在情况及其治疗数据。
共纳入238例IBD患儿,其中104例(44%)为克罗恩病(CD),130例(56%)为溃疡性结肠炎(UC),4例(0.016%)为未分类IBD(IBD-U)。平均年龄为174±47个月,56%为男性。238例中有47例(19.7%)在IBD诊断前有FC病史,这47例患者中有31例(65%)接受了聚乙二醇治疗。在FC组中,与无FC组相比,IBD诊断延迟[中位数(四分位间距[IQR]):分别为5个月(2.5 - 9.5)和2个月(0 - 4),p≤0.001]。在出现FC的UC患者中,内镜定位方面的差异具有统计学意义(p = 0.026),直肠炎和左侧结肠炎的患病率分别为30%和15%。
总之,我们的研究强调了IBD诊断时儿科患者便秘的患病率为19.7%,必须考虑到这一点以避免诊断延迟,并且这与UC儿科患者疾病范围有限相关。